Benjamin M. Gyori

I suppose if a drug is confirmed to have worked in a trial for a given disease, an INDRA Statement could be constructed to capture a causal drug-disease effect. Otherwise...

Thanks, these are good ideas! Currently not on the critical path, but we'll keep them in mind.

This is related to #231, we might link to the editable bioregistry.json directly from the website.

Great idea and it turns out there is, see e.g., https://github.dev/biopragmatics/bioregistry/blob/main/src/bioregistry/data/bioregistry.json#L14175-L14224. So in principle we could calculate the line numbers ahead of time and make links specific.

These look great to me! Why do you think the "New prefixes must start with a letter." constraint is necessary? There are some resources whose name happens to start with...

I agree with all of that, thanks!

This looks good! The section > Because the code is already set up in https://github.com/biopragmatics/bioregistry and https://github.com/biopragmatics/bioregistry-docker, external contributions are welcome. These should must be approved by a member of...

Thanks @allenbaron. I'm curious which cases showed differences between the DO-MeSH definitions. I think it's fairly common that there are two disease terms that are meant to be equivalent but...

This is a known issue in Reach and is going to be addressed very soon. Once section titles are correctly extracted by Reach I will comment here to let you...

Thanks! I think keeping number 4. and removing the second bullet point under 2. would be best. This way, the `chmod` instructions apply to both the manual download and the...